Hyderabad, Sept. 4 -- Aparna Pharmaceuticals Private Limited, a division of Aparna Group, a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and Advanced Drug Intermediates, today announced it has secured European union Good Manufacturing Practice (EUGMP) approval for its manufacturing facility located in Pydibhimavaram facility, Srikakulam district of Andhra Pradesh.
The Pydibhimavaram facility had already received approval from the United States Food and Drug Administration (USFDA) early last year.
Spread across 170,000 sq. mt. (40 acres), the facility currently produces around 250 MT per month of pharmaceutical APIs and advanced intermediates across multiple therapeutic areas, the Hyderabad-based pharma company said in ...